Skip to main content
. 2019 Dec 31;69(3):355–364. doi: 10.1007/s00262-019-02458-x

Fig. 2.

Fig. 2

Plasma HMGB1 profile plots over the course of NACT and sequential CRT for various patient categories. Wild-type or mutant tumor KRAS status (the upper panel). Negative or positive for a DMFS event at study censoring (the middle panel). Negative or positive for an OS event at study censoring. The dashed profile represents cases alive with metastatic disease at censoring (the lower panel). mut mutant, neg negative, pos positive, wt wild-type